|
|
 |
|
| | |
| | | | | | | |
sequence
|
|
PR:000001731 |
inhibin alpha chain isoform 1
|
INHA/iso:1
|
"An inhibin alpha chain that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05111-1 or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
organism-sequence
|
|
PR:P05111-1 |
inhibin alpha chain isoform 1 (human)
|
hINHA/iso:1
|
"An inhibin alpha chain isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036609 |
inhibin alpha chain isoform 1 mature form (human)
|
hINHA/iso:1/mature
|
"An inhibin alpha chain isoform 1 mature form in human. UniProtKB:P05111-1, 233-366." [PMID:17456790, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036610 |
inhibin alpha chain isoform 1 N-glycosylated 1 (human)
|
hINHA/iso:1/NGlyco:1
|
"An inhibin alpha chain isoform 1 N-glycosylated 1 in human. UniProtKB:P05111-1, Asn-146/Asn-268, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036611 |
inhibin alpha chain isoform 1 N-glycosylated 2 (human)
|
hINHA/iso:1/NGlyco:2
|
"An inhibin alpha chain isoform 1 N-glycosylated 2 in human. UniProtKB:P05111-1, Asn-146/Asn-268/Asn-302, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001737 |
inhibin alpha chain isoform 1 glycosylated form
|
INHA/iso:1/GlycoRes+
|
"An inhibin alpha chain isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001732 |
inhibin alpha chain isoform 1 cleaved and glycosylated form
|
INHA/iso:1/ClvGlyco+
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001733 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
|
INHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001736 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
|
INHA/iso:1/ClvNGlyco:1
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001738 |
inhibin alpha chain isoform 1 N-glycosylated 1
|
INHA/iso:1/NGlyco:1
|
"An inhibin alpha chain isoform 1 glycosylated form that is N-glycosylated at the Asn residue within the conserved N-glycosylation consensus site within the alphan N-terminal region, and in the first (or unique) consensus N-glycosylation site in the alpha C-terminal region. This is a glycosylated precursor for the mature inhibin alpha. Example: UniProtKB:P05111-1, Asn-146/Asn-268, MOD:00160." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036610 |
inhibin alpha chain isoform 1 N-glycosylated 1 (human)
|
hINHA/iso:1/NGlyco:1
|
"An inhibin alpha chain isoform 1 N-glycosylated 1 in human. UniProtKB:P05111-1, Asn-146/Asn-268, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001739 |
inhibin alpha chain isoform 1 N-glycosylated 2
|
INHA/iso:1/NGlyco:2
|
"An inhibin alpha chain isoform 1 glycosylated form that is N-glycosylated at the Asn residue located in the conserved N-glycosylation consensus site within the alphan N-terminal region, and at the Asn residues within the two consensus N-glycosylation sites within the alpha C-terminal region. This is a glycosylated precursor for the mature inhibin alpha. Example: UniProtKB:P05111-1, Asn-146/Asn-268/Asn-302, MOD:00160." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036611 |
inhibin alpha chain isoform 1 N-glycosylated 2 (human)
|
hINHA/iso:1/NGlyco:2
|
"An inhibin alpha chain isoform 1 N-glycosylated 2 in human. UniProtKB:P05111-1, Asn-146/Asn-268/Asn-302, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000021920 |
inhibin alpha chain isoform 1, signal peptide removed form
|
INHA/iso:1/SigPep-
|
"An inhibin alpha chain isoform 1 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001732 |
inhibin alpha chain isoform 1 cleaved and glycosylated form
|
INHA/iso:1/ClvGlyco+
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001733 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
|
INHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001736 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
|
INHA/iso:1/ClvNGlyco:1
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001735 |
inhibin alpha chain isoform 1 mature form
|
INHA/iso:1/mature
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by subsequent removal of the propeptide." [PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036609 |
inhibin alpha chain isoform 1 mature form (human)
|
hINHA/iso:1/mature
|
"An inhibin alpha chain isoform 1 mature form in human. UniProtKB:P05111-1, 233-366." [PMID:17456790, PRO:CNA]
|
Yes |
|
|
|
